预防性主动脉侧支栓塞预防血管腔内动脉瘤修复术后II型内漏的最新系统评价与荟萃分析
该系统评价与荟萃分析更新检索2019年1月1日至2022年5月29日文献,纳入4项新研究(含1项随机对照研究和1项全国注册回顾性研究),比较预防性主动脉侧支栓塞联合血管腔内动脉瘤修复与不栓塞的结局。结果显示栓塞组动脉瘤囊增大、II型内漏及因II型内漏再干预的发生率均低于对照组(OR分别为0.38、0.38、0.12),但作者认为仍需更高级别证据支持广泛改变实践。
要点
- 栓塞组动脉瘤囊增大发生率4.3% vs 对照组6.8%(OR 0.38,95%CI 0.26-0.55)。
- 栓塞组II型内漏发生率19.7% vs 对照组37.4%(OR 0.38,95%CI 0.30-0.47)。
- 栓塞组因II型内漏再干预发生率1.2% vs 对照组11.2%(OR 0.12,95%CI 0.06-0.23)。
核心结论
- 当前证据证实,在血管腔内动脉瘤修复术同时行预防性主动脉侧支栓塞,相比不栓塞,动脉瘤囊增大、II型内漏和再干预的发生率更低。
- 作者认为仍需更高级别证据支持广泛改变实践,包括成本效益数据和对破裂潜在影响的数据。
研究设计与样本
- 系统评价与荟萃分析,更新既往系统评价与荟萃分析,采用相同关键词和检索策略,补充检索2019年1月1日至2022年5月29日发表的所有文章。
- 共纳入4项新研究,包括1项随机对照研究和1项全国注册回顾性研究。
- 主要结局为动脉瘤囊增大的发生率。
主要发现
- 动脉瘤囊增大发生率:栓塞组4.3% vs 对照组6.8%(OR 0.38,95%CI 0.26-0.55)。
- II型内漏发生率:栓塞组19.7% vs 对照组37.4%(OR 0.38,95%CI 0.30-0.47)。
- 因II型内漏再干预发生率:栓塞组1.2% vs 对照组11.2%(OR 0.12,95%CI 0.06-0.23)。
临床怎么用
- 作者认为当前证据证实预防性主动脉侧支栓塞联合血管腔内动脉瘤修复可降低动脉瘤囊增大、II型内漏和再干预的发生率。
- 作者认为仍需更高级别证据支持广泛改变实践,包括成本效益数据和对破裂潜在影响的数据。
局限性
- 作者指出,既往系统评价与荟萃分析截至2019年的数据仅基于回顾性研究。
- 作者认为仍需更高级别证据支持广泛改变实践,包括成本效益数据和对破裂潜在影响的数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pre-emptive embolization of aortic side branches may be effective in preventing type II endoleaks (T2EL) based on a previous systematic review and meta-analysis by our group. Data up to 2019 was, however, only based on retrospective studies. The aim of the current study was to update the meta-analysis and evaluate the current evidence on this treatment strategy. METHODS: A systematic literature search was performed with the same keywords and strategies used in the previous study. The complementary search included all articles published from January 1, 2019, through May 29, 2022. The incidence of aneurysm sac growth was the primary outcome of interest. RESULTS: Four new studies were identified, including one randomized controlled study and one nationwide registry-based retrospective study. Overall, the incidence of sac size enlargement was 4.3% in the embolization group compared with 6.8% in the control group (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.26-0.55), the incidence of T2EL was 19.7% vs 37.4% (OR, 0.38; 95% CI, 0.30-0.47), and the incidence of reintervention for T2EL was 1.2% vs 11.2% (OR, 0.12; 95% CI, 0.06-0.23). CONCLUSIONS: Current evidence confirms lower incidence of aneurysm sac growth, T2EL, and reinterventions when pre-emptive embolization of aortic side branches is performed in conjunction with endovascular aneurysm repair, compared with no embolization. However, a higher level of evidence is still required to support a broad change of practice, including data on cost-effectiveness and on the potential effect on rupture.
引用
- Yu HYH, Lindström D, Wanhainen A, et al. An updated systematic review and meta-analysis of pre-emptive aortic side branch embolization to prevent type II endoleaks after endovascular aneurysm repair. J Vasc Surg. 2022. PMID: 36400361. doi:10.1016/j.jvs.2022.11.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。